Drug intelligence / Profile preview

streptococcus thermophilus TCI633

Development stage
Unknown
Lead developer
TCI Gene
Modality
Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Oral
01

Overview

Streptococcus thermophilus TCI633 is a probiotic bacterial strain originally isolated from human breast milk and developed by TCI Co., Ltd. The strain is characterized by its ability to colonize the gastrointestinal tract and endogenously produce hyaluronic acid (HA). This mechanism is intended to provide systemic benefits, particularly in the management of musculoskeletal conditions. Clinical and preclinical studies have investigated TCI633 for the treatment of knee osteoarthritis (KOA), where it has demonstrated potential in reducing synovial tissue inflammation, protecting cartilage, and improving joint function as measured by WOMAC scores and biomarkers like sCTX-II and sCRP. Beyond joint health, the strain is explored for its anti-aging properties and potential to improve skin hydration and collagen synthesis.

Other names
Streptococcus thermophilus TCI633DSM 28121DSM28121DSM-28121BCRC 910636BCRC910636BCRC-910636

Beyond the preview

Go deeper on streptococcus thermophilus TCI633.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on streptococcus thermophilus TCI633.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call